2021 EMCDDA expert meeting on the epidemiological indicator Drug-related deaths (DRD)
On 30 September-1 October 2021, the EMCDDA brings together more than sixty European and international experts for a meeting on the key indicator Drug-related deaths. The meeting provides a space for sharing and discussing new data, studies and experiences at regional, national and European level.
It also aims to facilitate technical work around the collection and analysis of the different components of this indicator: overdose and toxicological information from special mortality registers; data from the general mortality registers; mortality cohort studies; as well as developments in responses.
This page will be updated during the next weeks with more documents.
This year particular attention is given to:
- COVID-19, its impact on drug-related deaths and preparedness across Europe.
- Preliminary analysis and discussion of the DRD data reported in 2021.
- Mortality cohort studies among drug users for action oriented information.
- Recent trends and health threats.
- Responses to reduce overdose deaths, with a focus on take home naloxone and safe consumption rooms.
- EMCDDA standard protocol to collect data and report figures for the key indicator drug-related deaths (DRD-Standard, version 3.2)
- Frequently asked questions (FAQ): drug overdose deaths in Europe (updated: 31 August 2021)
- Drug-related deaths (DRD) in Europe: updates from the annual meeting of the EMCDDA DRD expert network